nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Pemetrexed—lung cancer	0.273	0.765	CrCtD
Raltitrexed—TYMS—lung cancer	0.147	1	CbGaD
Raltitrexed—TYMS—Pemetrexed—lung cancer	0.0962	0.498	CbGbCtD
Raltitrexed—Methotrexate—lung cancer	0.084	0.235	CrCtD
Raltitrexed—FPGS—Methotrexate—lung cancer	0.0462	0.239	CbGbCtD
Raltitrexed—Folic Acid—Pemetrexed—lung cancer	0.0363	0.153	CrCrCtD
Raltitrexed—Pralatrexate—Pemetrexed—lung cancer	0.0363	0.153	CrCrCtD
Raltitrexed—Methotrexate—Pemetrexed—lung cancer	0.0363	0.153	CrCrCtD
Raltitrexed—Tetrahydrofolic acid—Pemetrexed—lung cancer	0.0363	0.153	CrCrCtD
Raltitrexed—Leucovorin—Pemetrexed—lung cancer	0.0363	0.153	CrCrCtD
Raltitrexed—TYMS—Gemcitabine—lung cancer	0.0346	0.179	CbGbCtD
Raltitrexed—TYMS—Methotrexate—lung cancer	0.0163	0.0845	CbGbCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—lung cancer	0.0112	0.0471	CrCrCtD
Raltitrexed—Pemetrexed—Methotrexate—lung cancer	0.0112	0.0471	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—lung cancer	0.0112	0.0471	CrCrCtD
Raltitrexed—Leucovorin—Methotrexate—lung cancer	0.0112	0.0471	CrCrCtD
Raltitrexed—Folic Acid—Methotrexate—lung cancer	0.0112	0.0471	CrCrCtD
Raltitrexed—FPGS—respiratory system—lung cancer	0.000899	0.158	CbGeAlD
Raltitrexed—FPGS—bronchus—lung cancer	0.00074	0.13	CbGeAlD
Raltitrexed—FPGS—trachea—lung cancer	0.000664	0.117	CbGeAlD
Raltitrexed—FPGS—cardiac atrium—lung cancer	0.000624	0.11	CbGeAlD
Raltitrexed—TYMS—respiratory system—lung cancer	0.00059	0.104	CbGeAlD
Raltitrexed—TYMS—bronchus—lung cancer	0.000485	0.0855	CbGeAlD
Raltitrexed—FPGS—lung—lung cancer	0.000477	0.084	CbGeAlD
Raltitrexed—TYMS—bone marrow—lung cancer	0.000346	0.0609	CbGeAlD
Raltitrexed—FPGS—lymph node—lung cancer	0.000326	0.0575	CbGeAlD
Raltitrexed—TYMS—lung—lung cancer	0.000313	0.0551	CbGeAlD
Raltitrexed—Leucovorin—ABCC3—lung cancer	0.000262	0.178	CrCbGaD
Raltitrexed—TYMS—Docetaxel—Paclitaxel—lung cancer	0.000218	0.185	CbGdCrCtD
Raltitrexed—TYMS—lymph node—lung cancer	0.000214	0.0377	CbGeAlD
Raltitrexed—Pralatrexate—TYMS—lung cancer	0.000209	0.142	CrCbGaD
Raltitrexed—Leucovorin—TYMS—lung cancer	0.000209	0.142	CrCbGaD
Raltitrexed—Folic Acid—ABCC3—lung cancer	0.000169	0.115	CrCbGaD
Raltitrexed—Pemetrexed—TYMS—lung cancer	0.000167	0.113	CrCbGaD
Raltitrexed—TYMS—Erlotinib—Gefitinib—lung cancer	0.000163	0.138	CbGdCrCtD
Raltitrexed—TYMS—Podofilox—Teniposide—lung cancer	0.000117	0.0995	CbGdCrCtD
Raltitrexed—Methotrexate—ABCC3—lung cancer	0.000116	0.0783	CrCbGaD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—lung cancer	0.000109	0.0922	CbGdCrCtD
Raltitrexed—TYMS—Afatinib—Gefitinib—lung cancer	0.000106	0.0902	CbGdCrCtD
Raltitrexed—TYMS—Gefitinib—Erlotinib—lung cancer	0.000104	0.0884	CbGdCrCtD
Raltitrexed—Methotrexate—TYMS—lung cancer	9.22e-05	0.0625	CrCbGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	8.74e-05	0.00525	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ATP5H—lung cancer	8.7e-05	0.00523	CbGpPWpGaD
Raltitrexed—Folic Acid—ABCG2—lung cancer	8.21e-05	0.0556	CrCbGaD
Raltitrexed—FPGS—Metabolism—PLBD1—lung cancer	7.76e-05	0.00466	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	7.62e-05	0.00458	CbGpPWpGaD
Raltitrexed—TYMS—Vincristine—Vinorelbine—lung cancer	7.47e-05	0.0634	CbGdCrCtD
Raltitrexed—TYMS—Circadian rythm related genes—AHR—lung cancer	7.32e-05	0.0044	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—HSD17B10—lung cancer	7.1e-05	0.00426	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PGAM1—lung cancer	7.02e-05	0.00422	CbGpPWpGaD
Raltitrexed—TYMS—Vinorelbine—Vinblastine—lung cancer	6.99e-05	0.0592	CbGdCrCtD
Raltitrexed—TYMS—Podofilox—Etoposide—lung cancer	6.98e-05	0.0592	CbGdCrCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	6.66e-05	0.004	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CKB—lung cancer	6.6e-05	0.00396	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SDC4—lung cancer	6.55e-05	0.00394	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—ADCY1—lung cancer	6.52e-05	0.00392	CbGpPWpGaD
Raltitrexed—Folic Acid—CYP2E1—lung cancer	6.52e-05	0.0442	CrCbGaD
Raltitrexed—FPGS—Metabolism—GSTM2—lung cancer	6.2e-05	0.00373	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CNDP2—lung cancer	6.2e-05	0.00373	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CREBBP—lung cancer	6.12e-05	0.00367	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—RB1—lung cancer	6.09e-05	0.00366	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTMR3—lung cancer	6.03e-05	0.00363	CbGpPWpGaD
Raltitrexed—TYMS—Vinblastine—Vinorelbine—lung cancer	6.01e-05	0.0509	CbGdCrCtD
Raltitrexed—TYMS—Vincristine—Vinblastine—lung cancer	5.97e-05	0.0506	CbGdCrCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	5.94e-05	0.00357	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PGAM1—lung cancer	5.88e-05	0.00353	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SKI—lung cancer	5.78e-05	0.00347	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APP—lung cancer	5.63e-05	0.00338	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—lung cancer	5.63e-05	0.00338	CbGpPWpGaD
Raltitrexed—Methotrexate—ABCG2—lung cancer	5.62e-05	0.0381	CrCbGaD
Raltitrexed—FPGS—Disease—B4GALT5—lung cancer	5.61e-05	0.00337	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP2A7—lung cancer	5.61e-05	0.00337	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—SDC4—lung cancer	5.49e-05	0.0033	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2A—lung cancer	5.36e-05	0.00322	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	5.33e-05	0.0032	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RB1—lung cancer	5.29e-05	0.00318	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PXN—lung cancer	5.02e-05	0.00302	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—RRM1—lung cancer	5e-05	0.003	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTA3—lung cancer	5e-05	0.003	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKR1C1—lung cancer	4.92e-05	0.00295	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.84e-05	0.00291	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—B4GALT5—lung cancer	4.7e-05	0.00282	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTA4—lung cancer	4.57e-05	0.00275	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NPPA—lung cancer	4.52e-05	0.00272	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	4.51e-05	0.00271	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	4.5e-05	0.0027	CbGpPWpGaD
Raltitrexed—Asthenia—Erlotinib—lung cancer	4.5e-05	0.00113	CcSEcCtD
Raltitrexed—Discomfort—Gemcitabine—lung cancer	4.49e-05	0.00112	CcSEcCtD
Raltitrexed—Malaise—Cisplatin—lung cancer	4.48e-05	0.00112	CcSEcCtD
Raltitrexed—Pruritus—Topotecan—lung cancer	4.48e-05	0.00112	CcSEcCtD
Raltitrexed—Oedema—Irinotecan—lung cancer	4.47e-05	0.00112	CcSEcCtD
Raltitrexed—Feeling abnormal—Vinorelbine—lung cancer	4.46e-05	0.00112	CcSEcCtD
Raltitrexed—Diarrhoea—Vinblastine—lung cancer	4.46e-05	0.00112	CcSEcCtD
Raltitrexed—Dysgeusia—Etoposide—lung cancer	4.46e-05	0.00112	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTA2—lung cancer	4.46e-05	0.00268	CbGpPWpGaD
Raltitrexed—Leukopenia—Cisplatin—lung cancer	4.45e-05	0.00111	CcSEcCtD
Raltitrexed—Infection—Irinotecan—lung cancer	4.44e-05	0.00111	CcSEcCtD
Raltitrexed—Pruritus—Erlotinib—lung cancer	4.43e-05	0.00111	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vinorelbine—lung cancer	4.43e-05	0.00111	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—RB1—lung cancer	4.42e-05	0.00266	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PPIA—lung cancer	4.42e-05	0.00265	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ALDOA—lung cancer	4.38e-05	0.00263	CbGpPWpGaD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1A—lung cancer	4.38e-05	0.00263	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Irinotecan—lung cancer	4.38e-05	0.0011	CcSEcCtD
Raltitrexed—Dysgeusia—Paclitaxel—lung cancer	4.37e-05	0.00109	CcSEcCtD
Raltitrexed—Hepatic failure—Doxorubicin—lung cancer	4.36e-05	0.00109	CcSEcCtD
Raltitrexed—Oedema—Gemcitabine—lung cancer	4.35e-05	0.00109	CcSEcCtD
Raltitrexed—Diarrhoea—Topotecan—lung cancer	4.33e-05	0.00108	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—lung cancer	4.33e-05	0.00108	CcSEcCtD
Raltitrexed—Infection—Gemcitabine—lung cancer	4.32e-05	0.00108	CcSEcCtD
Raltitrexed—Hyperhidrosis—Irinotecan—lung cancer	4.32e-05	0.00108	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTA1—lung cancer	4.3e-05	0.00258	CbGpPWpGaD
Raltitrexed—Diarrhoea—Erlotinib—lung cancer	4.29e-05	0.00107	CcSEcCtD
Raltitrexed—Body temperature increased—Vinorelbine—lung cancer	4.28e-05	0.00107	CcSEcCtD
Raltitrexed—Abdominal pain—Vinorelbine—lung cancer	4.28e-05	0.00107	CcSEcCtD
Raltitrexed—Thrombocytopenia—Gemcitabine—lung cancer	4.26e-05	0.00107	CcSEcCtD
Raltitrexed—Anorexia—Irinotecan—lung cancer	4.26e-05	0.00107	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ABCC3—lung cancer	4.25e-05	0.00255	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	4.24e-05	0.00255	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Etoposide—lung cancer	4.23e-05	0.00106	CcSEcCtD
Raltitrexed—Anaemia—Etoposide—lung cancer	4.21e-05	0.00105	CcSEcCtD
Raltitrexed—Hyperhidrosis—Gemcitabine—lung cancer	4.21e-05	0.00105	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—AVP—lung cancer	4.2e-05	0.00252	CbGpPWpGaD
Raltitrexed—Discomfort—Cisplatin—lung cancer	4.18e-05	0.00105	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—EP300—lung cancer	4.17e-05	0.0025	CbGpPWpGaD
Raltitrexed—Anorexia—Gemcitabine—lung cancer	4.15e-05	0.00104	CcSEcCtD
Raltitrexed—Vomiting—Vinblastine—lung cancer	4.15e-05	0.00104	CcSEcCtD
Raltitrexed—Ill-defined disorder—Paclitaxel—lung cancer	4.14e-05	0.00104	CcSEcCtD
Raltitrexed—FPGS—Disease—ADCY1—lung cancer	4.14e-05	0.00249	CbGpPWpGaD
Raltitrexed—Anaemia—Paclitaxel—lung cancer	4.13e-05	0.00103	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—lung cancer	4.12e-05	0.00103	CcSEcCtD
Raltitrexed—FPGS—Metabolism—AKR1C1—lung cancer	4.12e-05	0.00247	CbGpPWpGaD
Raltitrexed—Malaise—Etoposide—lung cancer	4.11e-05	0.00103	CcSEcCtD
Raltitrexed—Headache—Vinblastine—lung cancer	4.08e-05	0.00102	CcSEcCtD
Raltitrexed—Leukopenia—Etoposide—lung cancer	4.08e-05	0.00102	CcSEcCtD
Raltitrexed—FPGS—Disease—ENO2—lung cancer	4.06e-05	0.00244	CbGpPWpGaD
Raltitrexed—Oedema—Cisplatin—lung cancer	4.06e-05	0.00102	CcSEcCtD
Raltitrexed—FPGS—Disease—SMARCA4—lung cancer	4.03e-05	0.00242	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PPP2R1B—lung cancer	4.03e-05	0.00242	CbGpPWpGaD
Raltitrexed—Infection—Cisplatin—lung cancer	4.03e-05	0.00101	CcSEcCtD
Raltitrexed—Vomiting—Topotecan—lung cancer	4.03e-05	0.00101	CcSEcCtD
Raltitrexed—Malaise—Paclitaxel—lung cancer	4.03e-05	0.00101	CcSEcCtD
Raltitrexed—Leukopenia—Paclitaxel—lung cancer	4e-05	0.001	CcSEcCtD
Raltitrexed—FPGS—Metabolism—UGT1A1—lung cancer	4e-05	0.0024	CbGpPWpGaD
Raltitrexed—Rash—Topotecan—lung cancer	3.99e-05	0.001	CcSEcCtD
Raltitrexed—Dermatitis—Topotecan—lung cancer	3.99e-05	0.000999	CcSEcCtD
Raltitrexed—Vomiting—Erlotinib—lung cancer	3.98e-05	0.000997	CcSEcCtD
Raltitrexed—Cough—Etoposide—lung cancer	3.97e-05	0.000995	CcSEcCtD
Raltitrexed—Thrombocytopenia—Cisplatin—lung cancer	3.97e-05	0.000994	CcSEcCtD
Raltitrexed—Headache—Topotecan—lung cancer	3.97e-05	0.000993	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Gemcitabine—lung cancer	3.97e-05	0.000993	CcSEcCtD
Raltitrexed—Rash—Erlotinib—lung cancer	3.95e-05	0.000989	CcSEcCtD
Raltitrexed—Dermatitis—Erlotinib—lung cancer	3.95e-05	0.000988	CcSEcCtD
Raltitrexed—Dyspepsia—Irinotecan—lung cancer	3.93e-05	0.000985	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	3.93e-05	0.00236	CbGpPWpGaD
Raltitrexed—Headache—Erlotinib—lung cancer	3.93e-05	0.000983	CcSEcCtD
Raltitrexed—Hyperhidrosis—Cisplatin—lung cancer	3.92e-05	0.000982	CcSEcCtD
Raltitrexed—Cough—Paclitaxel—lung cancer	3.9e-05	0.000976	CcSEcCtD
Raltitrexed—Asthenia—Vinorelbine—lung cancer	3.89e-05	0.000973	CcSEcCtD
Raltitrexed—Decreased appetite—Irinotecan—lung cancer	3.88e-05	0.000972	CcSEcCtD
Raltitrexed—Arrhythmia—Docetaxel—lung cancer	3.88e-05	0.000972	CcSEcCtD
Raltitrexed—Nausea—Vinblastine—lung cancer	3.87e-05	0.00097	CcSEcCtD
Raltitrexed—Anorexia—Cisplatin—lung cancer	3.87e-05	0.000968	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—FOXM1—lung cancer	3.87e-05	0.00232	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GNG11—lung cancer	3.85e-05	0.00232	CbGpPWpGaD
Raltitrexed—Alopecia—Docetaxel—lung cancer	3.84e-05	0.000962	CcSEcCtD
Raltitrexed—Pruritus—Vinorelbine—lung cancer	3.83e-05	0.00096	CcSEcCtD
Raltitrexed—Discomfort—Etoposide—lung cancer	3.83e-05	0.000959	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.83e-05	0.0023	CbGpPWpGaD
Raltitrexed—Pain—Irinotecan—lung cancer	3.82e-05	0.000957	CcSEcCtD
Raltitrexed—Constipation—Irinotecan—lung cancer	3.82e-05	0.000957	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	3.8e-05	0.00229	CbGpPWpGaD
Raltitrexed—Arthralgia—Paclitaxel—lung cancer	3.8e-05	0.000952	CcSEcCtD
Raltitrexed—Decreased appetite—Gemcitabine—lung cancer	3.78e-05	0.000947	CcSEcCtD
Raltitrexed—Nausea—Topotecan—lung cancer	3.76e-05	0.000942	CcSEcCtD
Raltitrexed—Discomfort—Paclitaxel—lung cancer	3.76e-05	0.00094	CcSEcCtD
Raltitrexed—TYMS—Metabolism—AZIN2—lung cancer	3.73e-05	0.00224	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—COL4A3BP—lung cancer	3.73e-05	0.00224	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—RB1—lung cancer	3.73e-05	0.00224	CbGpPWpGaD
Raltitrexed—Pain—Gemcitabine—lung cancer	3.72e-05	0.000932	CcSEcCtD
Raltitrexed—Constipation—Gemcitabine—lung cancer	3.72e-05	0.000932	CcSEcCtD
Raltitrexed—Nausea—Erlotinib—lung cancer	3.72e-05	0.000932	CcSEcCtD
Raltitrexed—Diarrhoea—Vinorelbine—lung cancer	3.71e-05	0.000928	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—lung cancer	3.71e-05	0.000928	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Cisplatin—lung cancer	3.7e-05	0.000925	CcSEcCtD
Raltitrexed—Infection—Etoposide—lung cancer	3.69e-05	0.000924	CcSEcCtD
Raltitrexed—FPGS—Disease—ENO1—lung cancer	3.69e-05	0.00222	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Irinotecan—lung cancer	3.68e-05	0.000922	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ALDOA—lung cancer	3.67e-05	0.00221	CbGpPWpGaD
Raltitrexed—Neutropenia—Methotrexate—lung cancer	3.66e-05	0.000917	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Irinotecan—lung cancer	3.65e-05	0.000915	CcSEcCtD
Raltitrexed—Dehydration—Doxorubicin—lung cancer	3.65e-05	0.000913	CcSEcCtD
Raltitrexed—Oedema—Paclitaxel—lung cancer	3.64e-05	0.000912	CcSEcCtD
Raltitrexed—Thrombocytopenia—Etoposide—lung cancer	3.64e-05	0.000911	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—MYC—lung cancer	3.63e-05	0.00218	CbGpPWpGaD
Raltitrexed—Infection—Paclitaxel—lung cancer	3.62e-05	0.000906	CcSEcCtD
Raltitrexed—Hyperhidrosis—Etoposide—lung cancer	3.59e-05	0.0009	CcSEcCtD
Raltitrexed—Feeling abnormal—Gemcitabine—lung cancer	3.59e-05	0.000898	CcSEcCtD
Raltitrexed—Thrombocytopenia—Paclitaxel—lung cancer	3.57e-05	0.000893	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NCOA3—lung cancer	3.56e-05	0.00214	CbGpPWpGaD
Raltitrexed—Anorexia—Etoposide—lung cancer	3.54e-05	0.000887	CcSEcCtD
Raltitrexed—Abdominal pain—Irinotecan—lung cancer	3.53e-05	0.000884	CcSEcCtD
Raltitrexed—Body temperature increased—Irinotecan—lung cancer	3.53e-05	0.000884	CcSEcCtD
Raltitrexed—Decreased appetite—Cisplatin—lung cancer	3.53e-05	0.000883	CcSEcCtD
Raltitrexed—Hyperhidrosis—Paclitaxel—lung cancer	3.52e-05	0.000882	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.52e-05	0.00212	CbGpPWpGaD
Raltitrexed—Anaemia—Docetaxel—lung cancer	3.5e-05	0.000876	CcSEcCtD
Raltitrexed—Anorexia—Paclitaxel—lung cancer	3.47e-05	0.00087	CcSEcCtD
Raltitrexed—Pain—Cisplatin—lung cancer	3.47e-05	0.000869	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ADCY1—lung cancer	3.47e-05	0.00208	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ABCG2—lung cancer	3.47e-05	0.00208	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—FOXM1—lung cancer	3.46e-05	0.00208	CbGpPWpGaD
Raltitrexed—Vomiting—Vinorelbine—lung cancer	3.44e-05	0.000862	CcSEcCtD
Raltitrexed—Body temperature increased—Gemcitabine—lung cancer	3.44e-05	0.000861	CcSEcCtD
Raltitrexed—Renal failure—Methotrexate—lung cancer	3.43e-05	0.000859	CcSEcCtD
Raltitrexed—FPGS—Disease—APP—lung cancer	3.43e-05	0.00206	CbGpPWpGaD
Raltitrexed—Rash—Vinorelbine—lung cancer	3.42e-05	0.000855	CcSEcCtD
Raltitrexed—Dermatitis—Vinorelbine—lung cancer	3.41e-05	0.000854	CcSEcCtD
Raltitrexed—Stomatitis—Methotrexate—lung cancer	3.4e-05	0.000852	CcSEcCtD
Raltitrexed—FPGS—Disease—FGF9—lung cancer	3.4e-05	0.00204	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ENO2—lung cancer	3.4e-05	0.00204	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—HPGDS—lung cancer	3.4e-05	0.00204	CbGpPWpGaD
Raltitrexed—Headache—Vinorelbine—lung cancer	3.39e-05	0.00085	CcSEcCtD
Raltitrexed—Conjunctivitis—Methotrexate—lung cancer	3.39e-05	0.000849	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—lung cancer	3.39e-05	0.000848	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PPP2R1B—lung cancer	3.38e-05	0.00203	CbGpPWpGaD
Raltitrexed—Sweating—Methotrexate—lung cancer	3.35e-05	0.000838	CcSEcCtD
Raltitrexed—Feeling abnormal—Cisplatin—lung cancer	3.34e-05	0.000837	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Paclitaxel—lung cancer	3.32e-05	0.000831	CcSEcCtD
Raltitrexed—Cough—Docetaxel—lung cancer	3.3e-05	0.000827	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTT1—lung cancer	3.3e-05	0.00198	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—lung cancer	3.28e-05	0.00197	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP2A6—lung cancer	3.26e-05	0.00196	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GCLC—lung cancer	3.26e-05	0.00196	CbGpPWpGaD
Raltitrexed—FPGS—Disease—JUNB—lung cancer	3.25e-05	0.00195	CbGpPWpGaD
Raltitrexed—Decreased appetite—Etoposide—lung cancer	3.23e-05	0.000809	CcSEcCtD
Raltitrexed—Arthralgia—Docetaxel—lung cancer	3.22e-05	0.000807	CcSEcCtD
Raltitrexed—Nausea—Vinorelbine—lung cancer	3.22e-05	0.000806	CcSEcCtD
Raltitrexed—Dyspepsia—Paclitaxel—lung cancer	3.21e-05	0.000803	CcSEcCtD
Raltitrexed—Body temperature increased—Cisplatin—lung cancer	3.21e-05	0.000803	CcSEcCtD
Raltitrexed—Asthenia—Irinotecan—lung cancer	3.21e-05	0.000803	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PPP2R1B—lung cancer	3.2e-05	0.00193	CbGpPWpGaD
Raltitrexed—Constipation—Etoposide—lung cancer	3.18e-05	0.000796	CcSEcCtD
Raltitrexed—Pain—Etoposide—lung cancer	3.18e-05	0.000796	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—CDKN1A—lung cancer	3.18e-05	0.00191	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ATP5H—lung cancer	3.17e-05	0.00191	CbGpPWpGaD
Raltitrexed—Neutropenia—Doxorubicin—lung cancer	3.17e-05	0.000794	CcSEcCtD
Raltitrexed—Decreased appetite—Paclitaxel—lung cancer	3.17e-05	0.000793	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—lung cancer	3.15e-05	0.0019	CbGpPWpGaD
Raltitrexed—Asthenia—Gemcitabine—lung cancer	3.12e-05	0.000782	CcSEcCtD
Raltitrexed—Constipation—Paclitaxel—lung cancer	3.12e-05	0.00078	CcSEcCtD
Raltitrexed—Pain—Paclitaxel—lung cancer	3.12e-05	0.00078	CcSEcCtD
Raltitrexed—Oedema—Docetaxel—lung cancer	3.09e-05	0.000773	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ENO1—lung cancer	3.09e-05	0.00186	CbGpPWpGaD
Raltitrexed—Pruritus—Gemcitabine—lung cancer	3.08e-05	0.000771	CcSEcCtD
Raltitrexed—Infection—Docetaxel—lung cancer	3.07e-05	0.000768	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—lung cancer	3.07e-05	0.000768	CcSEcCtD
Raltitrexed—Feeling abnormal—Etoposide—lung cancer	3.06e-05	0.000767	CcSEcCtD
Raltitrexed—Diarrhoea—Irinotecan—lung cancer	3.06e-05	0.000765	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—LMNA—lung cancer	3.06e-05	0.00184	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.06e-05	0.00184	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Etoposide—lung cancer	3.04e-05	0.000761	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—lung cancer	3.02e-05	0.000757	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.02e-05	0.00182	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Paclitaxel—lung cancer	3e-05	0.000752	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Paclitaxel—lung cancer	2.98e-05	0.000746	CcSEcCtD
Raltitrexed—Diarrhoea—Gemcitabine—lung cancer	2.98e-05	0.000746	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—lung cancer	2.97e-05	0.000744	CcSEcCtD
Raltitrexed—Stomatitis—Doxorubicin—lung cancer	2.95e-05	0.000738	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—lung cancer	2.94e-05	0.000737	CcSEcCtD
Raltitrexed—Body temperature increased—Etoposide—lung cancer	2.94e-05	0.000736	CcSEcCtD
Raltitrexed—Abdominal pain—Etoposide—lung cancer	2.94e-05	0.000736	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—lung cancer	2.94e-05	0.000736	CcSEcCtD
Raltitrexed—Asthenia—Cisplatin—lung cancer	2.91e-05	0.000729	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—lung cancer	2.9e-05	0.000725	CcSEcCtD
Raltitrexed—Body temperature increased—Paclitaxel—lung cancer	2.88e-05	0.000721	CcSEcCtD
Raltitrexed—Abdominal pain—Paclitaxel—lung cancer	2.88e-05	0.000721	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—PPP2R1B—lung cancer	2.87e-05	0.00172	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.85e-05	0.00171	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FOXO3—lung cancer	2.85e-05	0.00171	CbGpPWpGaD
Raltitrexed—Vomiting—Irinotecan—lung cancer	2.84e-05	0.000711	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.83e-05	0.0017	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PLBD1—lung cancer	2.83e-05	0.0017	CbGpPWpGaD
Raltitrexed—Rash—Irinotecan—lung cancer	2.82e-05	0.000705	CcSEcCtD
Raltitrexed—TYMS—Azacitidine—Gemcitabine—lung cancer	2.81e-05	0.0239	CbGdCrCtD
Raltitrexed—Dermatitis—Irinotecan—lung cancer	2.81e-05	0.000705	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—lung cancer	2.81e-05	0.000705	CcSEcCtD
Raltitrexed—Headache—Irinotecan—lung cancer	2.8e-05	0.000701	CcSEcCtD
Raltitrexed—Diarrhoea—Cisplatin—lung cancer	2.78e-05	0.000695	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP2E1—lung cancer	2.77e-05	0.00166	CbGpPWpGaD
Raltitrexed—Alopecia—Methotrexate—lung cancer	2.77e-05	0.000693	CcSEcCtD
Raltitrexed—Vomiting—Gemcitabine—lung cancer	2.77e-05	0.000693	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—lung cancer	2.77e-05	0.00166	CbGpPWpGaD
Raltitrexed—Rash—Gemcitabine—lung cancer	2.74e-05	0.000687	CcSEcCtD
Raltitrexed—Dermatitis—Gemcitabine—lung cancer	2.74e-05	0.000686	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NQO1—lung cancer	2.74e-05	0.00165	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—LMNA—lung cancer	2.73e-05	0.00164	CbGpPWpGaD
Raltitrexed—Headache—Gemcitabine—lung cancer	2.73e-05	0.000683	CcSEcCtD
Raltitrexed—Dyspepsia—Docetaxel—lung cancer	2.72e-05	0.000681	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.7e-05	0.00162	CbGpPWpGaD
Raltitrexed—Decreased appetite—Docetaxel—lung cancer	2.69e-05	0.000672	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—lung cancer	2.68e-05	0.00161	CbGpPWpGaD
Raltitrexed—Dysgeusia—Methotrexate—lung cancer	2.67e-05	0.000669	CcSEcCtD
Raltitrexed—Asthenia—Etoposide—lung cancer	2.67e-05	0.000668	CcSEcCtD
Raltitrexed—Nausea—Irinotecan—lung cancer	2.65e-05	0.000664	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—lung cancer	2.64e-05	0.000661	CcSEcCtD
Raltitrexed—Pain—Docetaxel—lung cancer	2.64e-05	0.000661	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—lung cancer	2.63e-05	0.00158	CbGpPWpGaD
Raltitrexed—Pruritus—Etoposide—lung cancer	2.63e-05	0.000658	CcSEcCtD
Raltitrexed—Asthenia—Paclitaxel—lung cancer	2.61e-05	0.000655	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—lung cancer	2.59e-05	0.00156	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HSD17B10—lung cancer	2.59e-05	0.00155	CbGpPWpGaD
Raltitrexed—Nausea—Gemcitabine—lung cancer	2.59e-05	0.000647	CcSEcCtD
Raltitrexed—Vomiting—Cisplatin—lung cancer	2.58e-05	0.000646	CcSEcCtD
Raltitrexed—Pruritus—Paclitaxel—lung cancer	2.58e-05	0.000645	CcSEcCtD
Raltitrexed—Rash—Cisplatin—lung cancer	2.56e-05	0.00064	CcSEcCtD
Raltitrexed—Dermatitis—Cisplatin—lung cancer	2.56e-05	0.00064	CcSEcCtD
Raltitrexed—Feeling abnormal—Docetaxel—lung cancer	2.55e-05	0.000637	CcSEcCtD
Raltitrexed—Diarrhoea—Etoposide—lung cancer	2.54e-05	0.000637	CcSEcCtD
Raltitrexed—Ill-defined disorder—Methotrexate—lung cancer	2.53e-05	0.000634	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Docetaxel—lung cancer	2.53e-05	0.000632	CcSEcCtD
Raltitrexed—FPGS—Disease—HES1—lung cancer	2.52e-05	0.00152	CbGpPWpGaD
Raltitrexed—Anaemia—Methotrexate—lung cancer	2.52e-05	0.000631	CcSEcCtD
Raltitrexed—Diarrhoea—Paclitaxel—lung cancer	2.49e-05	0.000624	CcSEcCtD
Raltitrexed—FPGS—Metabolism—STK11—lung cancer	2.47e-05	0.00148	CbGpPWpGaD
Raltitrexed—Malaise—Methotrexate—lung cancer	2.46e-05	0.000616	CcSEcCtD
Raltitrexed—Methotrexate—ALB—lung cancer	2.45e-05	0.0166	CrCbGaD
Raltitrexed—Abdominal pain—Docetaxel—lung cancer	2.44e-05	0.000611	CcSEcCtD
Raltitrexed—Body temperature increased—Docetaxel—lung cancer	2.44e-05	0.000611	CcSEcCtD
Raltitrexed—Leukopenia—Methotrexate—lung cancer	2.44e-05	0.000611	CcSEcCtD
Raltitrexed—Arrhythmia—Doxorubicin—lung cancer	2.42e-05	0.000607	CcSEcCtD
Raltitrexed—Nausea—Cisplatin—lung cancer	2.41e-05	0.000603	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.41e-05	0.00145	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CKB—lung cancer	2.4e-05	0.00144	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.4e-05	0.00144	CbGpPWpGaD
Raltitrexed—Alopecia—Doxorubicin—lung cancer	2.4e-05	0.0006	CcSEcCtD
Raltitrexed—Cough—Methotrexate—lung cancer	2.38e-05	0.000596	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.37e-05	0.00143	CbGpPWpGaD
Raltitrexed—Vomiting—Etoposide—lung cancer	2.36e-05	0.000592	CcSEcCtD
Raltitrexed—FPGS—Disease—ERCC2—lung cancer	2.36e-05	0.00142	CbGpPWpGaD
Raltitrexed—Rash—Etoposide—lung cancer	2.34e-05	0.000587	CcSEcCtD
Raltitrexed—Dermatitis—Etoposide—lung cancer	2.34e-05	0.000586	CcSEcCtD
Raltitrexed—Methotrexate—ABCB1—lung cancer	2.34e-05	0.0158	CrCbGaD
Raltitrexed—Headache—Etoposide—lung cancer	2.33e-05	0.000583	CcSEcCtD
Raltitrexed—Arthralgia—Methotrexate—lung cancer	2.32e-05	0.000581	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.32e-05	0.00139	CbGpPWpGaD
Raltitrexed—Vomiting—Paclitaxel—lung cancer	2.32e-05	0.00058	CcSEcCtD
Raltitrexed—Dysgeusia—Doxorubicin—lung cancer	2.31e-05	0.000579	CcSEcCtD
Raltitrexed—FPGS—Disease—ERBB3—lung cancer	2.31e-05	0.00139	CbGpPWpGaD
Raltitrexed—Rash—Paclitaxel—lung cancer	2.3e-05	0.000575	CcSEcCtD
Raltitrexed—Dermatitis—Paclitaxel—lung cancer	2.3e-05	0.000575	CcSEcCtD
Raltitrexed—Discomfort—Methotrexate—lung cancer	2.29e-05	0.000574	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTP1—lung cancer	2.28e-05	0.00137	CbGpPWpGaD
Raltitrexed—Headache—Paclitaxel—lung cancer	2.28e-05	0.000572	CcSEcCtD
Raltitrexed—TYMS—Metabolism—CNDP2—lung cancer	2.26e-05	0.00136	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM2—lung cancer	2.26e-05	0.00136	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CAT—lung cancer	2.22e-05	0.00134	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—lung cancer	2.22e-05	0.00133	CbGpPWpGaD
Raltitrexed—Asthenia—Docetaxel—lung cancer	2.22e-05	0.000555	CcSEcCtD
Raltitrexed—Infection—Methotrexate—lung cancer	2.21e-05	0.000554	CcSEcCtD
Raltitrexed—FPGS—Disease—TERT—lung cancer	2.21e-05	0.00133	CbGpPWpGaD
Raltitrexed—Nausea—Etoposide—lung cancer	2.21e-05	0.000553	CcSEcCtD
Raltitrexed—TYMS—Metabolism—MTMR3—lung cancer	2.2e-05	0.00132	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Doxorubicin—lung cancer	2.19e-05	0.000549	CcSEcCtD
Raltitrexed—Pruritus—Docetaxel—lung cancer	2.19e-05	0.000547	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—lung cancer	2.18e-05	0.000547	CcSEcCtD
Raltitrexed—Thrombocytopenia—Methotrexate—lung cancer	2.18e-05	0.000546	CcSEcCtD
Raltitrexed—Nausea—Paclitaxel—lung cancer	2.16e-05	0.000542	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ABCB1—lung cancer	2.16e-05	0.0013	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.15e-05	0.00129	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Methotrexate—lung cancer	2.15e-05	0.000539	CcSEcCtD
Raltitrexed—FPGS—Disease—FGFR1—lung cancer	2.15e-05	0.00129	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PGAM1—lung cancer	2.14e-05	0.00129	CbGpPWpGaD
Raltitrexed—Malaise—Doxorubicin—lung cancer	2.13e-05	0.000533	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TYMS—lung cancer	2.12e-05	0.00128	CbGpPWpGaD
Raltitrexed—Anorexia—Methotrexate—lung cancer	2.12e-05	0.000531	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—lung cancer	2.11e-05	0.000529	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—lung cancer	2.11e-05	0.000529	CcSEcCtD
Raltitrexed—FPGS—Disease—HIF1A—lung cancer	2.11e-05	0.00127	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTM1—lung cancer	2.1e-05	0.00126	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.1e-05	0.00126	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.09e-05	0.00126	CbGpPWpGaD
Raltitrexed—Cough—Doxorubicin—lung cancer	2.06e-05	0.000516	CcSEcCtD
Raltitrexed—TYMS—Metabolism—CYP2A7—lung cancer	2.04e-05	0.00123	CbGpPWpGaD
Raltitrexed—FPGS—Disease—APOA1—lung cancer	2.04e-05	0.00123	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—lung cancer	2.03e-05	0.000508	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.03e-05	0.00122	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.02e-05	0.00122	CbGpPWpGaD
Raltitrexed—Arthralgia—Doxorubicin—lung cancer	2.01e-05	0.000503	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—JUN—lung cancer	2.01e-05	0.00121	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SDC4—lung cancer	2e-05	0.0012	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP1A1—lung cancer	1.99e-05	0.0012	CbGpPWpGaD
Raltitrexed—Discomfort—Doxorubicin—lung cancer	1.99e-05	0.000497	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ERCC2—lung cancer	1.97e-05	0.00119	CbGpPWpGaD
Raltitrexed—Vomiting—Docetaxel—lung cancer	1.96e-05	0.000492	CcSEcCtD
Raltitrexed—Dyspepsia—Methotrexate—lung cancer	1.96e-05	0.000491	CcSEcCtD
Raltitrexed—Rash—Docetaxel—lung cancer	1.95e-05	0.000488	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—lung cancer	1.95e-05	0.000487	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—lung cancer	1.94e-05	0.00117	CbGpPWpGaD
Raltitrexed—Decreased appetite—Methotrexate—lung cancer	1.94e-05	0.000485	CcSEcCtD
Raltitrexed—Headache—Docetaxel—lung cancer	1.94e-05	0.000484	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.93e-05	0.00116	CbGpPWpGaD
Raltitrexed—Oedema—Doxorubicin—lung cancer	1.93e-05	0.000483	CcSEcCtD
Raltitrexed—Infection—Doxorubicin—lung cancer	1.92e-05	0.000479	CcSEcCtD
Raltitrexed—Pain—Methotrexate—lung cancer	1.9e-05	0.000477	CcSEcCtD
Raltitrexed—Thrombocytopenia—Doxorubicin—lung cancer	1.89e-05	0.000473	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.88e-05	0.00113	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Doxorubicin—lung cancer	1.86e-05	0.000467	CcSEcCtD
Raltitrexed—FPGS—Disease—APC—lung cancer	1.86e-05	0.00112	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KIT—lung cancer	1.86e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—lung cancer	1.85e-05	0.00111	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGF—lung cancer	1.84e-05	0.00111	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—lung cancer	1.84e-05	0.00046	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—lung cancer	1.83e-05	0.000459	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—lung cancer	1.83e-05	0.000459	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.83e-05	0.0011	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—RRM1—lung cancer	1.82e-05	0.0011	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA3—lung cancer	1.82e-05	0.0011	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Methotrexate—lung cancer	1.82e-05	0.000456	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—lung cancer	1.81e-05	0.00109	CbGpPWpGaD
Raltitrexed—Abdominal pain—Methotrexate—lung cancer	1.76e-05	0.000441	CcSEcCtD
Raltitrexed—Body temperature increased—Methotrexate—lung cancer	1.76e-05	0.000441	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.76e-05	0.00044	CcSEcCtD
Raltitrexed—FPGS—Disease—BRAF—lung cancer	1.75e-05	0.00105	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.73e-05	0.00104	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6R—lung cancer	1.73e-05	0.00104	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CREBBP—lung cancer	1.73e-05	0.00104	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—B4GALT5—lung cancer	1.71e-05	0.00103	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—APOA1—lung cancer	1.71e-05	0.00103	CbGpPWpGaD
Raltitrexed—Dyspepsia—Doxorubicin—lung cancer	1.7e-05	0.000425	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.68e-05	0.00101	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—lung cancer	1.68e-05	0.00042	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTA4—lung cancer	1.67e-05	0.001	CbGpPWpGaD
Raltitrexed—Pain—Doxorubicin—lung cancer	1.65e-05	0.000413	CcSEcCtD
Raltitrexed—Constipation—Doxorubicin—lung cancer	1.65e-05	0.000413	CcSEcCtD
Raltitrexed—FPGS—Disease—MAP2K1—lung cancer	1.65e-05	0.00099	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.64e-05	0.000988	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CD—lung cancer	1.64e-05	0.000983	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA2—lung cancer	1.62e-05	0.000976	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BIRC5—lung cancer	1.62e-05	0.000974	CbGpPWpGaD
Raltitrexed—Asthenia—Methotrexate—lung cancer	1.6e-05	0.0004	CcSEcCtD
Raltitrexed—Feeling abnormal—Doxorubicin—lung cancer	1.59e-05	0.000398	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—lung cancer	1.58e-05	0.000395	CcSEcCtD
Raltitrexed—Pruritus—Methotrexate—lung cancer	1.58e-05	0.000394	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—TERT—lung cancer	1.57e-05	0.000943	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA1—lung cancer	1.57e-05	0.000942	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CG—lung cancer	1.56e-05	0.000937	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.55e-05	0.000934	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCC3—lung cancer	1.55e-05	0.000931	CbGpPWpGaD
Raltitrexed—Body temperature increased—Doxorubicin—lung cancer	1.52e-05	0.000382	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—lung cancer	1.52e-05	0.000382	CcSEcCtD
Raltitrexed—Diarrhoea—Methotrexate—lung cancer	1.52e-05	0.000381	CcSEcCtD
Raltitrexed—TYMS—Metabolism—AKR1C1—lung cancer	1.5e-05	0.000902	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—POMC—lung cancer	1.48e-05	0.000892	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MDM2—lung cancer	1.47e-05	0.000881	CbGpPWpGaD
Raltitrexed—FPGS—Disease—RAF1—lung cancer	1.46e-05	0.000878	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UGT1A1—lung cancer	1.46e-05	0.000875	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CREBBP—lung cancer	1.45e-05	0.000869	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB2—lung cancer	1.45e-05	0.000869	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.43e-05	0.000858	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—lung cancer	1.43e-05	0.000857	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—lung cancer	1.43e-05	0.000857	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD4—lung cancer	1.42e-05	0.000856	CbGpPWpGaD
Raltitrexed—Vomiting—Methotrexate—lung cancer	1.42e-05	0.000354	CcSEcCtD
Raltitrexed—FPGS—Disease—PTGS2—lung cancer	1.41e-05	0.000849	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GNG11—lung cancer	1.4e-05	0.000844	CbGpPWpGaD
Raltitrexed—Rash—Methotrexate—lung cancer	1.4e-05	0.000351	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—lung cancer	1.4e-05	0.000351	CcSEcCtD
Raltitrexed—Headache—Methotrexate—lung cancer	1.39e-05	0.000349	CcSEcCtD
Raltitrexed—Asthenia—Doxorubicin—lung cancer	1.38e-05	0.000346	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.38e-05	0.00083	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CD—lung cancer	1.37e-05	0.000824	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RB1—lung cancer	1.37e-05	0.000821	CbGpPWpGaD
Raltitrexed—Pruritus—Doxorubicin—lung cancer	1.36e-05	0.000341	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ALB—lung cancer	1.35e-05	0.000813	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALDOA—lung cancer	1.34e-05	0.000804	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—lung cancer	1.33e-05	0.000797	CbGpPWpGaD
Raltitrexed—Nausea—Methotrexate—lung cancer	1.32e-05	0.000331	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—lung cancer	1.32e-05	0.00033	CcSEcCtD
Raltitrexed—TYMS—Metabolism—NCOA3—lung cancer	1.3e-05	0.00078	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCG2—lung cancer	1.26e-05	0.000759	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ADCY1—lung cancer	1.26e-05	0.000759	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HPGDS—lung cancer	1.24e-05	0.000744	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ENO2—lung cancer	1.24e-05	0.000744	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1A—lung cancer	1.24e-05	0.000742	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—lung cancer	1.23e-05	0.000741	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPP2R1B—lung cancer	1.23e-05	0.00074	CbGpPWpGaD
Raltitrexed—Vomiting—Doxorubicin—lung cancer	1.23e-05	0.000307	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—RB1—lung cancer	1.22e-05	0.000734	CbGpPWpGaD
Raltitrexed—Rash—Doxorubicin—lung cancer	1.22e-05	0.000304	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—lung cancer	1.21e-05	0.000304	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—lung cancer	1.21e-05	0.000729	CbGpPWpGaD
Raltitrexed—Headache—Doxorubicin—lung cancer	1.21e-05	0.000302	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTT1—lung cancer	1.2e-05	0.000722	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.2e-05	0.000722	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CB—lung cancer	1.19e-05	0.000718	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2A6—lung cancer	1.19e-05	0.000714	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GCLC—lung cancer	1.19e-05	0.000714	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—lung cancer	1.18e-05	0.000711	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EP300—lung cancer	1.18e-05	0.000706	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.17e-05	0.000701	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—lung cancer	1.15e-05	0.000287	CcSEcCtD
Raltitrexed—FPGS—Disease—SRC—lung cancer	1.14e-05	0.000687	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ENO1—lung cancer	1.13e-05	0.000677	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—lung cancer	1.1e-05	0.000662	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—lung cancer	1.1e-05	0.000661	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—lung cancer	1.07e-05	0.000645	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK3—lung cancer	1.05e-05	0.000633	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MDM2—lung cancer	1.04e-05	0.000626	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—lung cancer	1.03e-05	0.00062	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—lung cancer	1.02e-05	0.000616	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—lung cancer	1.01e-05	0.00061	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000607	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—lung cancer	1e-05	0.000602	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NQO1—lung cancer	9.99e-06	0.0006	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—lung cancer	9.84e-06	0.000592	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—lung cancer	9.82e-06	0.00059	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—lung cancer	9.46e-06	0.000569	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—lung cancer	9.34e-06	0.000561	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—lung cancer	9.07e-06	0.000545	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—STK11—lung cancer	9e-06	0.000541	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—lung cancer	8.78e-06	0.000527	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—lung cancer	8.7e-06	0.000523	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK3—lung cancer	8.37e-06	0.000503	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—EP300—lung cancer	8.35e-06	0.000502	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTP1—lung cancer	8.33e-06	0.0005	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—lung cancer	8.14e-06	0.000489	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CAT—lung cancer	8.1e-06	0.000487	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—lung cancer	8.05e-06	0.000483	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—lung cancer	7.88e-06	0.000474	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—lung cancer	7.7e-06	0.000463	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM1—lung cancer	7.65e-06	0.00046	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK3—lung cancer	7.48e-06	0.00045	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—lung cancer	7.28e-06	0.000438	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—lung cancer	7.28e-06	0.000437	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1A1—lung cancer	7.25e-06	0.000436	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ERCC2—lung cancer	7.2e-06	0.000432	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—lung cancer	7.1e-06	0.000427	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—APOA1—lung cancer	6.22e-06	0.000374	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—lung cancer	5.98e-06	0.000359	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—lung cancer	5.95e-06	0.000357	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—lung cancer	5.68e-06	0.000341	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—POMC—lung cancer	5.41e-06	0.000325	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CREBBP—lung cancer	5.27e-06	0.000317	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—lung cancer	5e-06	0.0003	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALB—lung cancer	4.93e-06	0.000296	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—lung cancer	4.35e-06	0.000262	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—lung cancer	4.31e-06	0.000259	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—lung cancer	3.76e-06	0.000226	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—lung cancer	3.59e-06	0.000216	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—lung cancer	2.65e-06	0.00016	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—lung cancer	2.17e-06	0.00013	CbGpPWpGaD
